X4 Pharmaceuticals (XFOR) Insider Trading & Ownership $2.74 +0.04 (+1.29%) As of 01:09 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock X4 Pharmaceuticals (NASDAQ:XFOR) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage2.37%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$2,559.36Number OfInsiders Selling(Last 12 Months)4Amount OfInsider Selling(Last 12 Months)$412,578.00 Get XFOR Insider Trade Alerts Want to know when executives and insiders are buying or selling X4 Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address XFOR Insider Buying and Selling by Quarter X4 Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails5/16/2025Mark BaldryInsiderBuy1,032$2.48$2,559.36 1/24/2025Adam S. MostafaCFOSell2,492$13.50$33,642.00 1/24/2025Mark BaldryInsiderSell971$13.50$13,108.50 1/24/2025Mary DibiaseCOOSell741$13.50$10,003.50 1/24/2025Paula RaganCEOSell2,549$13.50$34,411.50 10/15/2024Paula RaganCEOSell1,063$16.80$17,858.40 10/7/2024Adam S. MostafaCFOSell7,688$16.50$126,852.00 10/7/2024Mark BaldryInsiderSell370$17.40$6,438.00 10/7/2024Mary DibiaseCOOSell2,256$17.10$38,577.60 10/7/2024Paula RaganCEOSell7,981$16.50$131,686.50 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. (Data available from 1/1/2013 forward) XFOR Insider Trading Activity - Frequently Asked Questions Who is on X4 Pharmaceuticals's Insider Roster? The list of insiders at X4 Pharmaceuticals includes Adam S Mostafa, Arthur Taveras, Israel Niv, Mark Baldry, Mary Dibiase, Michael S Wyzga, Murray Stewart, Paula Ragan, and Tuvia Barlev. Learn more on insiders at XFOR. What percentage of X4 Pharmaceuticals stock is owned by insiders? 2.37% of X4 Pharmaceuticals stock is owned by insiders. Learn more on XFOR's insider holdings. Which X4 Pharmaceuticals insiders have been buying company stock? The following insiders have purchased XFOR shares in the last 24 months: Mark Baldry ($2,559.36), and Michael S Wyzga ($29,988.00). How much insider buying is happening at X4 Pharmaceuticals? Insiders have purchased a total of 1,865 XFOR shares in the last 24 months for a total of $32,547.36 bought. Which X4 Pharmaceuticals insiders have been selling company stock? The following insiders have sold XFOR shares in the last 24 months: Adam S Mostafa ($223,764.00), Arthur Taveras ($13,301.40), Mark Baldry ($27,014.40), Mary Dibiase ($122,872.20), Murray Stewart ($137,853.00), and Paula Ragan ($471,236.70). How much insider selling is happening at X4 Pharmaceuticals? Insiders have sold a total of 56,163 X4 Pharmaceuticals shares in the last 24 months for a total of $1,202,735.70 sold. X4 Pharmaceuticals Key ExecutivesDr. Paula Ragan Ph.D. (Age 54)CEO, President & Director Compensation: $1.01MMr. Adam S. Mostafa (Age 44)CFO, Treasurer & Corporate Secretary Compensation: $700.78k1 recent tradesDr. Christophe Arbet-Engels M.B.A. (Age 62)M.D., Ph.D., Chief Medical Officer Compensation: $379.8kDr. Richard Peters M.D. (Age 61)Ph.D., Founder Dr. Renato T. Skerlj Ph.D.FounderDr. Keith T. Flaherty M.D. (Age 53)Founder & Member of Corporate Advisory Board Dr. Mary DiBiase Ph.D. (Age 63)Chief Operating Officer Compensation: $661.59kDr. Arthur Taveras Ph.D. (Age 60)Chief Scientific Officer Dr. Robert David Arbeit (Age 76)Senior Vice President of Clinical Development and Translational Research Mr. Mark Baldry M.B.A. (Age 60)Chief Commercial Officer More Insider Trading Tools from MarketBeat Related Companies Inozyme Pharma Insider Ownership Caribou Biosciences Insider Ownership Adaptimmune Therapeutics Insider Ownership Exicure Insider Ownership ESSA Pharma Insider Ownership Elutia Insider Ownership Sutro Biopharma Insider Ownership Pyxis Oncology Insider Ownership Jasper Therapeutics Insider Ownership IGM Biosciences Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles UnitedHealth Insiders Double Down: Is UNH Stock a Value Play?Sprouts Stock: Insider Sales, But Strong Bullish Signals5 Hot Small-Cap Insiders Bought at the Peak of Tariff FearsThe Top-Ranked Insider Buys From April by Market CapMcDonald’s Insiders Sell Shares! Investors Should Do the Opposite This page (NASDAQ:XFOR) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding X4 Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share X4 Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy XFOR Stock Free XFOR Stock Alerts